Marianne P. Allen

Array ( [id] => 6048420 [patent_doc_number] => 20110207664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins' [patent_app_type] => utility [patent_app_number] => 13/016728 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 55519 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207664.pdf [firstpage_image] =>[orig_patent_app_number] => 13016728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618161 [patent_doc_number] => 20130023473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITION FOR THE PRESERVATION OF VASCULAR ENDOTHELIAL CELL BARRIER INTEGRITY' [patent_app_type] => utility [patent_app_number] => 13/522828 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17110 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159670 [patent_doc_number] => 20110159015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4' [patent_app_type] => utility [patent_app_number] => 12/977361 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21011 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159015.pdf [firstpage_image] =>[orig_patent_app_number] => 12977361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174202 [patent_doc_number] => 20110177058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING HGF/MET' [patent_app_type] => utility [patent_app_number] => 12/975828 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33563 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177058.pdf [firstpage_image] =>[orig_patent_app_number] => 12975828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066223 [patent_doc_number] => 20110243912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Growth Factor Binding Constructs Materials and Methods' [patent_app_type] => utility [patent_app_number] => 12/971865 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36044 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243912.pdf [firstpage_image] =>[orig_patent_app_number] => 12971865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6079930 [patent_doc_number] => 20110142792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Compositions for Increasing Polypeptide Stability and Activity, and Related Methods' [patent_app_type] => utility [patent_app_number] => 12/950349 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 31126 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142792.pdf [firstpage_image] =>[orig_patent_app_number] => 12950349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000845 [patent_doc_number] => 20110117168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'METHODS AND COMPOSITIONS FOR SOFT TISSUE REPAIR' [patent_app_type] => utility [patent_app_number] => 12/949149 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 22300 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117168.pdf [firstpage_image] =>[orig_patent_app_number] => 12949149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617293 [patent_doc_number] => 20130022606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE' [patent_app_type] => utility [patent_app_number] => 13/514995 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 25752 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007122 [patent_doc_number] => 20110059153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'USE OF ANTI-CYTOKINE AGENTS FOR TREATING CARPAL AND TARSAL TUNNEL SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/947131 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5685 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059153.pdf [firstpage_image] =>[orig_patent_app_number] => 12947131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038419 [patent_doc_number] => 20110091468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Connective tissue growth factor antibodies' [patent_app_type] => utility [patent_app_number] => 12/927243 [patent_app_country] => US [patent_app_date] => 2010-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27947 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091468.pdf [firstpage_image] =>[orig_patent_app_number] => 12927243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416668 [patent_doc_number] => 20120244169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'Treatment for Radiation-Induced Disorders' [patent_app_type] => utility [patent_app_number] => 13/508524 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16193 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413350 [patent_doc_number] => 08697386 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Methods and compositions for modulating hepsin activation of macrophage-stimulating protein' [patent_app_type] => utility [patent_app_number] => 13/503636 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 42277 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 246 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8027957 [patent_doc_number] => 08143058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Human CDR-grafted antibody and antibody fragment thereof' [patent_app_type] => utility [patent_app_number] => 12/903780 [patent_app_country] => US [patent_app_date] => 2010-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28647 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143058.pdf [firstpage_image] =>[orig_patent_app_number] => 12903780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323490 [patent_doc_number] => 20120195897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'HUMAN DOMAIN ANTIBODIES AGAINST COMPONENTS OF THE HUMAN INSULIN-LIKE GROWTH FACTOR (IGF) SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/499758 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7856 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8095653 [patent_doc_number] => 20120083420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/891793 [patent_app_country] => US [patent_app_date] => 2010-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 40629 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083420.pdf [firstpage_image] =>[orig_patent_app_number] => 12891793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134361 [patent_doc_number] => 20110008282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'IL-1alpha immunization induces autoantibodies protective against atherosclerosis' [patent_app_type] => utility [patent_app_number] => 12/888044 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3962 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008282.pdf [firstpage_image] =>[orig_patent_app_number] => 12888044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8502074 [patent_doc_number] => 20120301482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF LUNG INJURY' [patent_app_type] => utility [patent_app_number] => 13/392134 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13663 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8431138 [patent_doc_number] => 20120253013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'Early Growth Transcription Factors and Their Therapeutic Use' [patent_app_type] => utility [patent_app_number] => 13/391681 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5951 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482766 [patent_doc_number] => 20120282173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/391171 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30007 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317481 [patent_doc_number] => 08232258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and variants thereof, and their use' [patent_app_type] => utility [patent_app_number] => 12/858189 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7636 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12858189 [rel_patent_id] =>[rel_patent_doc_number] =>)